Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.
Journal: Frontiers in immunology
Year: June 01, 2024
Oncologist
5
No OPD information available
Triple-Negative Breast Cancer
Breast Cancer
Interstitial Nephritis
Minimal Change Disease
Tongue Cancer
Mun N. Hui is a male healthcare provider who specializes in treating various conditions such as Triple-Negative Breast Cancer, Breast Cancer, Interstitial Nephritis, Minimal Change Disease, and Tongue Cancer.
Mun N. Hui helps patients by using his special skills and treatments to care for them. He communicates with patients in a way that makes them feel comfortable and safe, which is why patients trust him. Patients appreciate his kindness and expertise in treating their medical conditions.
Mun N. Hui stays updated with the latest medical knowledge and research to provide the best care for his patients. He attends conferences, reads medical journals, and collaborates with other healthcare professionals to learn new information and techniques.
In his work, Mun N. Hui collaborates well with colleagues and other medical professionals. He values teamwork and believes that working together leads to better patient outcomes. His relationships with colleagues are based on respect, trust, and a shared commitment to providing excellent care.
Mun N. Hui's dedication to his patients has made a positive impact on many lives. His treatments have improved the health and well-being of patients with various medical conditions. Patients have shared stories of how Mun N. Hui's care and expertise have helped them through difficult times.
One of Mun N. Hui's notable publications is "Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein." This publication shows his involvement in cutting-edge research to improve patient care.
Mun N. Hui is also involved in a clinical trial titled "A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and Safety of Niraparib to Placebo in Participants With Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer With Molecular Disease Based on Presence of Circulating Tumor DNA After Definitive Therapy (ZEST)." This trial demonstrates his commitment to advancing medical knowledge and finding new treatments for patients.
Overall, Mun N. Hui is a dedicated healthcare provider who uses his skills, knowledge, and compassion to make a positive impact on the lives of his patients.
Journal: Frontiers in immunology
Year: June 01, 2024
Enrollment Status: Active not recruiting
Published: July 22, 2024
Intervention Type: Drug
Study Drug: Niraparib
Study Phase: Phase 3
Mun N. Hui is an amazing Oncologist who truly cares about his patients. He explained everything clearly and made me feel at ease throughout my treatment. Highly recommend!
Dr. Mun N. Hui is a compassionate and knowledgeable Oncologist. He took the time to listen to my concerns and provided excellent care. I am grateful for his expertise.
I had a great experience with Dr. Mun N. Hui as my Oncologist. He is kind, understanding, and skilled in his field. I felt confident in his care every step of the way.
Mun N. Hui is a top-notch Oncologist in Camperdown. He is professional, thorough, and truly dedicated to his patients' well-being. I couldn't have asked for better care.
Dr. Mun N. Hui is an exceptional Oncologist who goes above and beyond for his patients. His expertise and compassion make a real difference in the lives of those he treats.
I highly recommend Mun N. Hui as an Oncologist. He is not only knowledgeable but also caring and supportive. I felt confident in his treatment plan and grateful for his care.
Dr. Mun N. Hui is a fantastic Oncologist who provides personalized and compassionate care. He made me feel comfortable and supported throughout my treatment journey.